Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 94.18x is 86% below its estimated 1-year average of 650.30x, near the low end of its estimated 1-year range (94.18x–1183.64x).
As of 2026-10-06T12:50:32.061Z.
Calculation as of: 2026-10-06T12:50:32.061Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b9d80053686f16721d19c62710da14dda18ff2c6e5fba2adc15c1c35f0ac96a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
94.18x
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
22.35x
median of 137 covered companies
CURRENT VS SECTOR MEDIAN
+321.39%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.15B
EV/EBIT Ratio
94.18x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
EV/EBIT Ratio
N/A
TTM Avg
142.94x
3Y Avg
142.94x
5Y Avg
142.94x
Market Cap
$3.09B
EV/EBIT Ratio
N/A
TTM Avg
9.47x
3Y Avg
9.47x
5Y Avg
9.47x
Market Cap
$2.87B
EV/EBIT Ratio
39.99x
TTM Avg
46.98x
3Y Avg
64.49x
5Y Avg
64.49x
Market Cap
$2.87B
EV/EBIT Ratio
199.47x
TTM Avg
169.00x
3Y Avg
169.00x
5Y Avg
169.00x
Market Cap
$3.44B
EV/EBIT Ratio
36.27x
TTM Avg
33.32x
3Y Avg
35.69x
5Y Avg
35.69x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.15B | 94.18x | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 142.94x | 142.94x | 142.94x |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 9.47x | 9.47x | 9.47x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 39.99x | 46.98x | 64.49x | 64.49x |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 199.47x | 169.00x | 169.00x | 169.00x |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 36.27x | 33.32x | 35.69x | 35.69x |
| Celcuity Inc. (CELC)vs › | $3.59B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 14.17x | 12.70x | 46.55x | 42.04x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-10-05 | 102.12x |
| 2026-10-02 | 102.16x |
| 2026-10-01 | 102.67x |
| 2026-09-30 | 107.20x |
| 2026-09-29 | 108.47x |
| 2026-09-28 | 110.77x |
| 2026-09-25 | 109.14x |
| 2026-09-24 | 106.56x |
| 2026-09-23 | 107.00x |
| 2026-09-22 | 112.55x |
| 2026-09-21 | 105.33x |
| 2026-09-18 | 103.03x |
| 2026-09-17 | 107.32x |
| 2026-09-16 | 106.05x |
| 2026-09-15 | 95.61x |
| 2026-09-14 | 98.63x |
| 2026-09-11 | 97.12x |
| 2026-09-10 | 95.10x |
| 2026-09-09 | 96.92x |
| 2026-09-08 | 99.10x |
| 2026-09-04 | 97.16x |
| 2026-09-03 | 96.21x |
| 2026-09-02 | 96.96x |
| 2026-09-01 | 96.56x |
| 2026-08-31 | 97.44x |
| 2026-08-28 | 96.68x |
| 2026-08-27 | 101.01x |
| 2026-08-26 | 102.08x |
| 2026-08-25 | 100.97x |
| 2026-08-24 | 100.65x |
| 2026-08-21 | 101.84x |
| 2026-08-20 | 102.91x |
| 2026-08-19 | 107.32x |
| 2026-08-18 | 107.63x |
| 2026-08-17 | 103.94x |
| 2026-08-14 | 106.24x |
| 2026-08-13 | 104.82x |
| 2026-08-12 | 106.60x |
| 2026-08-11 | 106.40x |
| 2026-08-10 | 105.17x |
| 2026-08-07 | 102.67x |
| 2026-08-06 | 107.20x |
| 2026-08-05 | 1116.00x |
| 2026-08-04 | 1072.92x |
| 2026-08-03 | 1069.29x |
| 2026-07-31 | 1106.33x |
| 2026-07-30 | 1151.83x |
| 2026-07-29 | 1146.60x |
| 2026-07-28 | 1169.14x |
| 2026-07-27 | 1145.79x |
| 2026-07-24 | 1126.06x |
| 2026-07-23 | 1125.26x |
| 2026-07-22 | 1148.21x |
| 2026-07-21 | 1162.70x |
| 2026-07-20 | 1133.31x |
| 2026-07-17 | 1171.96x |
| 2026-07-16 | 1141.77x |
| 2026-07-15 | 1143.38x |
| 2026-07-14 | 1104.32x |
| 2026-07-13 | 1116.80x |
| 2026-07-10 | 1141.77x |
| 2026-07-09 | 1183.64x |
| 2026-07-08 | 1172.37x |
| 2026-07-07 | 1138.95x |
| 2026-07-06 | 1074.53x |
| 2026-07-02 | 1064.06x |
| 2026-07-01 | 1065.27x |
| 2026-06-30 | 1080.57x |
| 2026-06-29 | 1102.31x |
| 2026-06-26 | 1111.97x |
| 2026-06-25 | 1099.49x |
| 2026-06-24 | 1126.87x |
| 2026-06-23 | 1082.58x |
| 2026-06-22 | 1098.28x |
| 2026-06-18 | 1080.16x |
| 2026-06-17 | 1080.57x |
| 2026-06-16 | 1058.42x |
| 2026-06-15 | 1054.80x |
| 2026-06-12 | 1006.48x |
| 2026-06-11 | 1014.94x |
| 2026-06-10 | 960.18x |
| 2026-06-09 | 942.46x |
| 2026-06-08 | 892.14x |
| 2026-06-05 | 879.65x |
| 2026-06-04 | 908.64x |
| 2026-06-03 | 884.49x |
| 2026-06-02 | 861.94x |
| 2026-06-01 | 889.32x |
| 2026-05-29 | 888.91x |
| 2026-05-28 | 888.11x |
| 2026-05-27 | 876.43x |
| 2026-05-26 | 874.82x |
| 2026-05-22 | 864.76x |
| 2026-05-21 | 870.80x |
| 2026-05-20 | 849.05x |
| 2026-05-19 | 810.00x |
| 2026-05-18 | 831.34x |
| 2026-05-15 | 883.28x |
| 2026-05-14 | 893.34x |
| 2026-05-13 | 898.17x |
| 2026-05-12 | 857.91x |
| 2026-05-11 | 880.06x |
| 2026-05-08 | 877.24x |
| 2026-05-07 | 856.70x |
